Manganese (Mn) is a potent neurotoxin. We hypothesize that PARK2, a strong Parkinson's disease (PD) genetic risk factor, alters neuronal vulnerability to modifiers of cellular Mn status, particularly at the level of mitochondrial dysfunction and oxidative stress. The long-term goal of this research is to elucidate the basis of Mn-induced neurotoxicity and to identify mechanistic-based neuroprotective strategies to mitigate human Mn exposure risk. Our approach will utilize a novel high-throughput assay of intracellular Mn levels to identify small molecule modifiers of cellular Mn status and neurotoxicity. Genetic modifiers of Mn transport and toxicity will be defined and translational studies of existing and newly identified genetic and small molecule modifiers of Mn toxicity will be performed utilizing a primary human neuronal model system based upon human induced pluripotent stem cell (hiPSC) technology.
Aim 1 will identify lead compounds that alter neuronal Mn transport and toxicity in vitro using striatal and mesencephalic murine neuronal cell lines and in vivo using C. elegans.
Aim 2 will delineate functional pathways that regulate Mn transport and toxicity in vivo and in vitro.
Specific Aim 3 will test the hypothesis that human neuronal models of PD exhibit increased sensitivity to perturbations of cellular Mn status.
These specific aims hold the promise of delineating common initiator signals for the modulation of Mn neurotoxicity, shedding light on mechanisms and susceptibility associated with exposure to this metal. This dual-PI proposal is bolstered by its use of innovative state-of-the-art complimentary approaches in diverse model systems.

Public Health Relevance

The proposed studies will (1) provide novel and innovative information on functional and hierarchal relationships between small molecule modifiers of cellular manganese (Mn) status and Mn neurotoxicity, (2) identify novel therapeutic modalities for Mn-induced neurotoxicity, and (3) delineate gene-environment interactions within and across species in the integrated systems response to Mn. Our multidisciplinary approach seeks to define the functional domains that regulate key nodes of interaction between Mn and biological systems and the role genetic traits of susceptibility play in mediating molecular mechanisms of neurological disease influence by Mn exposure.

National Institute of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Research Project (R01)
Project #
Application #
Study Section
Neurotoxicology and Alcohol Study Section (NAL)
Program Officer
Kirshner, Annette G
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine
Schools of Medicine
United States
Zip Code
Aboud, Asad A; Tidball, Andrew M; Kumar, Kevin K et al. (2015) PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper. Neurobiol Dis 73:204-12
Karki, Pratap; Smith, Keisha; Johnson Jr, James et al. (2015) Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity. Neurochem Res 40:380-8
Karki, Pratap; Smith, Keisha; Johnson Jr, James et al. (2015) Role of transcription factor yin yang 1 in manganese-induced reduction of astrocytic glutamate transporters: Putative mechanism for manganese-induced neurotoxicity. Neurochem Int 88:53-9
Bornhorst, Julia; Chakraborty, Sudipta; Meyer, Sören et al. (2014) The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of ?-synuclein in C. elegans. Metallomics 6:476-90
Leyva-Illades, Dinorah; Chen, Pan; Zogzas, Charles E et al. (2014) SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity. J Neurosci 34:14079-95
Nguyen, Thuy T; Aschner, Michael (2014) F3 -Isoprostanes as a Measure of in vivo Oxidative Damage in Caenorhabditis elegans. Curr Protoc Toxicol 62:11.17.1-11.17.13
Bowman, Aaron B; Aschner, Michael (2014) Considerations on manganese (Mn) treatments for in vitro studies. Neurotoxicology 41:141-2
Exil, Vernat; Ping, Li; Yu, Yingchun et al. (2014) Activation of MAPK and FoxO by manganese (Mn) in rat neonatal primary astrocyte cultures. PLoS One 9:e94753
Andrade, V; Mateus, M L; Santos, D et al. (2014) Arsenic and manganese alter lead deposition in the rat. Biol Trace Elem Res 158:384-91
da Silva Santos, Vivian; Bisen-Hersh, Emily; Yu, Yingchun et al. (2014) Anthocyanin-rich açaí (Euterpe oleracea Mart.) extract attenuates manganese-induced oxidative stress in rat primary astrocyte cultures. J Toxicol Environ Health A 77:390-404

Showing the most recent 10 out of 88 publications